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Abstract
With increased activity and reduced financial and human resources, there is a need for automation in clinical bacteriology. Initial pro-
cessing of clinical samples includes repetitive and fastidious steps. These tasks are suitable for automation, and several instruments are
now available on the market, including the WASP (Copan), Previ-Isola (BioMerieux), Innova (Becton-Dickinson) and Inoqula (KIESTRA)
systems. These new instruments allow efficient and accurate inoculation of samples, including four main steps: (i) selecting the appropri-
ate Petri dish; (ii) inoculating the sample; (iii) spreading the inoculum on agar plates to obtain, upon incubation, well-separated bacterial
colonies; and (iv) accurate labelling and sorting of each inoculated media. The challenge for clinical bacteriologists is to determine what
is the ideal automated system for their own laboratory. Indeed, different solutions will be preferred, according to the number and vari-
ety of samples, and to the types of sample that will be processed with the automated system. The final choice is troublesome, because
audits proposed by industrials risk being biased towards the solution proposed by their company, and because these automated systems
may not be easily tested on site prior to the final decision, owing to the complexity of computer connections between the laboratory
information system and the instrument. This article thus summarizes the main parameters that need to be taken into account for
choosing the optimal system, and provides some clues to help clinical bacteriologists to make their choice.
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Introduction
Most clinical bacteriology laboratories are experiencing an
increase in the number of samples to be processed on a
daily basis. As an example, in our clinical bacteriology labora-
tory in Lausanne’s university hospital, the number of samples
to be investigated has steadily increased by about 4% per
year, and this does not take into account the increased need
for culture for epidemiological investigations owing to methi-
cillin-resistant Staphylococcus aureus or to outbreaks of
vancomycin-resistant Enterococcus [1]. However, human
resources are not following this trend of increased number
of samples, mainly because of strong financial pressure and
resource shortages. Laboratory automation thus represents
an appealing solution, especially for sample inoculation, which
is a fastidious, repetitive process.
Pre-analytical handling of samples has been greatly
improved in recent years by improved laboratory informa-
tion systems (LISs) and increased use of bar-coding to trace
samples and downstream processes, such as subculture, iden-
tification steps, and aliquoting [2–4]. However, despite
improved LISs, the time spent on pre-analytical handling of
samples and inoculation remains important, and in our own
laboratory, which processes a mean of 300 samples per day
and employs ten full-time laboratory technicians, we
observed that about 24% of all technician activities related to
sample reception, inoculation and Gram staining are dedi-
cated to the inoculation of agar plates and broth (Fig. 1).
Thus, 50–70% of the time spent by full-time technicians may
be saved by automation of this task.
A first generation of automated plate streakers was devel-
oped more than 20 years ago [5]. However, the level of
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automation was still limited, and the automated inoculation
instruments initially available, such as the Inoculab (Dynacon),
had only unidirectional informatic interfaces. Although
updated with bi-directional connections with the LIS, the sec-
ond-generation Inoculab LQH system (Dynacon) is only able
to plate specimens starting from a single type of container
(i.e. sterile urine container), and has a limited capacity of 38
inoculated plates, all loaded in a single silo [6]. Thus, these
first-generation and second-generation systems were not
developed enough to allow efficient, high-throughput and
accurate inoculation of samples, including the following four
main steps:
1 selecting the appropriate Petri dish
2 inoculating the sample efficiently
3 spreading the inoculum on agar plates to obtain, upon
incubation, well-separated bacterial colonies
4 accurate labelling and sorting of each inoculated medium.
Very recently, third-generation instruments have become
available on the market; these fulfil all of these prerequisites
for automated handling of specimens in bacteriology labora-
tories. These new instruments include the WASP (Copan),
Previ-Isola (BioMerieux), Innova (Becton-Dickinson) and
Inoqula (KIESTRA) systems. The current challenge for each
clinical bacteriologist is now to determine the ideal auto-
mated system for his or her own laboratory. Indeed, differ-
ent solutions will be preferred, according to the types of
sample, and to the variety and amount of samples that will
be processed with a given automated instrument. However,
this choice is difficult, owing to the limited data available in
the scientific literature, partially because of the very recent
availability of these systems in clinical laboratories, and par-
tially because of the excessive level of confidentiality sur-
rounding results obtained with prototypes. This review thus
provides clues to guide the choice of clinical bacteriologists
and provides a list of instrument characteristics that need to
be considered (Table 1). This list should: (i) help for compar-
ison between systems; and (ii) pinpoint the parameters that
are important to choose an ideal automated system.
How to Choose the Ideal Equipment?
Instrument characteristics
The third-generation systems currently available on the
market differ in a variety of respects (Table 2). One of the
main differences between WASP, Previ-Isola, Innova and
Inoqula is the solution used to inoculate the sample. Thus,
sterile loops, combs or beads are, respectively, used with
WASP, Previ-Isola, and Inoqula. Innova also uses sterile
loops. The use of different applicators implies that the
streaking is also different, and the comb used by Previ-Isola
does not allow inoculation of plates in classical semiquantita-
tive or quantitative ways, but rather provides circular semi-
quantitative inoculation (Fig. 2a). It is expected that the
reproducibility of the inoculation process will be higher with
FIG. 1. Partition (%) of the workload in our bacteriology laboratory at the sample reception unit. Time was assessed by self-reporting ongoing
activity at 15-min intervals; activities had to be assigned to one of the seven categories presented on the graph. Note that as much as 24% of
technician time is devoted to the inoculation of agar plates and broths. LIS, laboratory information system; TB, tuberculosis.
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automated instruments than with inoculation by hand, as
demonstrated for Previ-Isola and WASP [6,7]. Moreover, in
these two recent studies, it has been shown that the num-
ber of isolated colonies is much higher with Previ-Isola and
WASP than when inoculation is performed manually [6,7],
as expected, given the wide and regular spreading of the
inoculum over the entire agar plate obtained with Previ-Isola
and WASP, respectively (Fig. 2a,b). Although peer-reviewed
data are lacking for the KIESTRA system, it seems that the
use of magnetic beads also results in a high number of iso-
lated colonies (Fig. 2c) as compared with what is obtained
manually (Fig. 2d).
Other important differences between the different sys-
tems are the plate throughput per hour, the robustness of
the robotic system, the level of automation (including cap-
ping/uncapping and selection of plates), and the connections
of the instruments with the LIS. Moreover, some ‘automated’
systems may require significant technician time to feed the
machine, and others are not fully automated (i.e. manual
interactive version of the KIESTRA system). Thus, some
automated inoculation systems include slide spreading
(Innova, Inoqula, and WASP) and/or slide staining (Innova).
This may be a semi-automated task (Innova and Inoqula) or
be fully automated as part of a supplementary module
(WASP). It is noteworthy that, when agar and broth inocula-
tion are tightly coupled with microscopy slide preparation,
the overall performance of the automated system may
decrease with a lower number of agar plates/h.
Characteristics of the laboratory
The choice of the ideal instrument is also highly dependent
on the characteristics of the laboratory and on the expected
use of automation. Thus, as an example, some large labora-
tories intend to use automation only for urines. In this spe-
cific situation, the cost of consumables and performance
(number of plates per hour) will represent the main parame-
ters for the decision. In contrast, when a laboratory intends
to automate the inoculation of most samples, the decision
complexity greatly increases. If the laboratory receives sam-
ples of low diversity and uses a low number of different
inoculation protocols, the constraints on the choice of
instrument will be lower than in a university hospital such as
ours, where very diverse samples are handled. This diversity
of samples introduces a constraint on the instrument, which
needs to accommodate a large variety of containers. How-
ever, a parameter that is even more important than the
diversity of samples is the proportion of samples obtained in
a liquid format, which are easily processed with all auto-
mated instruments, and the proportion of swabs, stools, and
tissues, for which solutions clearly differ from one manufac-
turer to another. In our laboratory, as swab samples repre-
sent about 34% of received samples (Table 3), the use of
swabs such as those commercialized by Copan will be con-
sidered, because these swabs allow accurate and easy release
of the sample, and its straightforward transformation in a
liquid format, which is amenable to automated culture with
most systems. In addition, one should remain aware that not
all samples will be suitable for automation, and in our labora-
tory we will continue to inoculate a large variety of samples
manually, such as cerebrospinal fluids, catheters (Macki
method [8]), port-a-cath needles, joint prostheses, prosthetic
valves, and vascular prostheses. Moreover, for some very
low-volume specimens and/or small biopsy tissue samples,
manual handling of the specimen will be preferred.
The variety of inoculation protocols used daily in a given
laboratory will also greatly impact on the final choice of an
automated system, as some automated systems, such as
WASP, provide as many as nine different agar plate input
TABLE 1. Instrument characteristics that should be taken
into account for choosing the ideal automated inoculation
system
Instrument characteristics
General
Size, weight
Electrical requirement (V/W, etc.)
Noise (decibels)
Technical characteristics
Productivity
Number of agar plates/h
Number of broths/h
Time spent in inoculating an agar plate
Inoculation
Semiquantitative, quantitative, circular, custom
Use of re-usable or dispensable devices
Type of inoculation device (bead, calibrated loop, etc.)
Consumables only provided by the manufacturer (captive product)
Samples
Various containers
Liquid and/or semi-liquid samples
Capacity of samples pre-processing loading
Automated capping/uncapping
Non-inoculated and inoculated media
Possible on agar, biplate agar, broth media, etc
Capacity of broth and agar pre-processing loading
Number of silos available for agar plates
Sorting according to samples and/or incubation atmosphere
Relationship with laboratory information system
Bi-directional
TCP/IP link, coding protocol
Need for an additional interface
Accuracy and quality control
Reproducibility
Comparison with another system
Risk of sample contamination
Traceability (stickers, etc.)
Biosecurity issues
HEPA filter
Maintenance
Cost and frequency of maintenance
Technical support from the company (availability, delay, etc.)
Options
Automated smear preparation
Automated transfer to incubator
Chain of automation including automated reading of broth and/or agar plates
Plate inoculation for antimicrobial disk susceptibility tests
TCP/IP, Transmission Control Protocol/Internet Protocol.
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silos, whereas there are currently only five silos in Previ-
Isola. As an example, in our diagnostic bacteriology labora-
tory, where more than 160 different plating protocols are
used, 20–30 of which are performed on a regular basis, i.e.
at least once a day, and where a large variety of agar plates
are inoculated (Table 4), we will prefer systems with a high
FIG. 2. Agar plates inoculated (a) with Previ-
Isola, (b) with WASP, (c) withInoqula, and (d)
manually. Note that isolated colonies were
generally obtained, although high inocula were
tested (about 106 bacteria/mL). The use of the
Previ-Isola comb leads to circular semiquanti-
tative inoculation (a), whereas, with WASP an-
d Inoqula, both single-streaking (b, d) and
four-quadrant inoculation (not shown) may be
performed. Only 1 lL of urine was inoculated
with the Inoqula bead (c), whereas 10 lL of
the same urine was inoculated manually (d).
Note that automated inoculation allow us to
obtain more isolated colonies than manual in-
oculation, at least with Previ-Isola and Inoqula
(Rice and Baruch, 109th ASM, 2009, Poster
C064; Sturm et al., 20th ECCMID, 2010, Pos-
ter 1766).
TABLE 2. Comparison of the four different third-generation automated systems currently available on the market; informa-
tion was mainly deduced or derived from company websites, as available in March 2011 [http://www.copanusa.com/index.php/
products/wasp/; http://www.biomerieux-usa.com/servlet/srt/bio/usa/dynPage?doc=USA_PRD_LST_G_PRD_USA_17; http://
www.dynacon.ca/en/solutions/innova.html; http://www.kiestra.nl/pageid=19/Total_Lab_Automation.html]
WASP Previ-Isola Innova Inoqula-FLA
Company (country) Copan (Italy) BioMerieux (France) Becton-Dickinson (USA) KIESTRA (The Netherlands)
Inoculation device Calibrated loopa Combs Calibrated loopa Beads
Type of inoculation Four quadrants, single
streaking, bi-plate, etc.
Circular inoculation
(semicircular for bi-plate)
Four quadrants, single streaking,
bi-plate, etc.
Four quadrants, single
streaking, bi-plate, etc.
Use of dispensable
devices
Re-usable metal loops Disposable combsb and
disposable pipette tipsc
Re-usable loops, disposable
pipette tipsc
Re-usable beads, disposable
pipette tipsc
Agar plate loading
capacity
Nine silos (350 agar plates) Five silos (270 agar plates) Six silos (270 agar plates) Six buffersd (720 agar plates)
Sample loading capacity 72 e-swab tubes 114 samples 200 containers (on 5 drawers) NA
Productivity (plates/h) 180 plates/h 180 plates/h 180 plates/h 400 plates/h
Decapping/recapping Automated Manuale Automated Automated
Agitation/centrifugation Automated agitation and
centrifugation, per specimene
No automated
agitation/centrifugation
Automated agitation, per rackf Automated agitation, per specimeng
aCalibrated tri-loop device (Triquetra) and bi-loop device for WASP and Innova, respectively, which allows inoculation of 1, 10 and 30 lL.
bOne comb per agar plate.
cOne pipette tip per liquid sample.
dEach KIESTRA buffer may receive up to 120 agar plates; the number of buffers might be further increased if needed.
eContainers are placed in racks already decapped (biosecurity issue and need for new caps when unloading the samples).
fAny type of container may be agitated; however, all samples loaded on a given rack will all be agitated; Inoqula-FLA, Inoqula full laboratory automation.
gAutomated pre-analytical handling of the specimen (agitation/centrifugation) may be specified for each specimen (different protocols for each specimen); however, centrifuga-
tion device only for Copan Uriswab and not for any type of container.
NA, information not available.
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number of input agar silos. However, this parameter is not
crucial, as it should be combined with the number of agar
plates inoculated per hour. Indeed, if the capacity of a system
with many silos is insufficient, two automated plating instru-
ments may be used, and this will double the number of input
agar silos available. Thus, the number of samples processed
also greatly influences the choice of a particular machine.
Importantly, the number of agar plates that should be inocu-
lated per hour is not simply the number of agar plates inocu-
lated in a median working day (about 1000 plates/day in our
laboratory) divided by 24 h (42 plates/h), or divided by 9 h
for a laboratory open only from 8 a.m. to 5 p.m. (111 plates/h),
but should ideally be the maximum number of plates that
need to be inoculated during activity peaks, i.e. about
220 plates/h (Fig. 3).
Other specific issues
Biosecurity is another important issue that needs to be con-
sidered when a system is being chosen. Indeed, given the
increasing number of multiresistant bacteria (i.e. extensively
drug-resistant Mycobacterium tuberculosis [9]), the system
should ideally cap and uncap samples and perform all pro-
cesses that may generate aerosols in a confined area. The
biosafety issue is not restricted to tuberculosis and respira-
tory tract specimens. Thus, another example is the risk of
cytomegalovirus infection that may occur among our labora-
tory staff (especially when pregnant), owing to the occur-
rence of very high levels of cytomegalovirus in urines from
infected newborns. This is especially important because
automated inoculation systems are at least dedicated to the
inoculation of urines.
To help bacteriologists in their decision, several compa-
nies selling automated instruments propose an audit by a
third partner. We may wonder whether this third partner is
really objective and provides an unbiased opinion, or
whether the companies actually use such a third partner to
influence our final choice rather than to help us in our deci-
sion. The final choice is also complicated by the fact that
automated systems may not easily be tested on site, owing
to the complexity of computer connections between the
instruments and the LIS.
Of course, a variety of intermediate solutions may make
sense, such as acquiring a progressively automated inocula-
tion system that will initially be used only for liquid samples
such as urines, before the level of automation is extended. In
this perspective, the acquisition of several automated instru-
ments may be appealing, as it allows increased flexibility.
However, this advantage is counterbalanced by the possible
increased maintenance costs and increased need for space.
The possibility of having a full chain of automation is also
appealing [10,11]. Thus, in addition to sorting agar plates
and/or slide preparation (see above), some systems, such as
KIESTRA, also provide belts that allow automated transport
of inoculated agar plates in incubators with different atmo-
spheres. However, some automated systems, such as Previ-
Isola, which provide circular inoculation may not be compati-
ble with automated readers (Telebacteriology) and auto-
mated colony-picking systems provided by another company,
such as KIESTRA [10]. Thus, before choosing a system that
provides unusual inoculation, clinical bacteriologists should
TABLE 3. Proportions of different main types of specimen
received in our diagnostic laboratory; note that most speci-
mens received are liquid, and that swabs also represent a
very high number of specimens
Type of
specimen
Specimens
per week
Percentages of
specimens (%)
Condition before
specimen processing
Swabs 304 34 Liquida
Stools 94 10 Solid
Tissue specimen 44 5 Solid
Liquid specimen 463 51 Liquid
aUsing Copan swabs.
TABLE 4. Main media used to inoculate specimen in our
bacteriology laboratory; the mean number of media used
per week was assessed over a 1-year period
Media No. per week
MacConkey agar 482
Chocolate agar 304
Columbia with human blood agar 238
Thioglycolate broth 219
Chromogenic urine agar 217
Schaedler’s agar 143
Chocolate agar with bacitracine 135
Columbia agar with sheep blood 127
Columbia agar with sheep blood with optochin disk 98
Chromogenic yeast agar 77
Gardnerella agar 75
Sabouraud agar 68
Chromogenic Campylobacter agar 65
Selenite broth 65
Chromogenic Salmonella agar 65
Cycloserine–cefoxitin–fructose agar 52
Granada agar 40
Lim broth 40
FIG. 3. Partition in percentage of the arrival of the specimen for
processing (working hours 08:00–17:00).
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be aware that they will be captives of this system for some
downstream automated applications. Overall, we may hope
that companies that are now working on the solutions of
tomorrow will see the importance of maintaining a high level
of compatibility with other systems, rather than playing the
non-productive game of delimiting their market.
Conclusion
The challenge for each clinical bacteriologist is to determine
the ideal automated system suited to his or her own labora-
tory. Indeed, different solutions will be preferred, according
to the number and variety of samples, and the types of sample
that will be processed with the automated handling system.
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